Passage Bio, Inc.
PASG · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $25,383 | $21,925 | $35,189 |
| - Cash | $52,773 | $57,626 | $63,357 | $37,573 |
| + Debt | $20,795 | $24,731 | $25,116 | $25,476 |
| Enterprise Value | – | -$7,512 | -$16,316 | $23,092 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$200 | $0 | -$719 |
| % Margin | – | – | – | – |
| EBITDA | -$7,439 | -$9,185 | -$13,621 | -$12,306 |
| % Margin | – | – | – | – |
| Net Income | -$7,749 | -$9,385 | -$15,405 | -$12,725 |
| % Margin | – | – | – | – |
| EPS Diluted | -2.45 | -2.96 | -4.96 | -4.1 |
| % Growth | 17.2% | 40.3% | -21% | – |
| Operating Cash Flow | -$4,853 | -$6,330 | -$13,847 | -$8,444 |
| Capital Expenditures | $0 | $0 | $0 | -$14 |
| Free Cash Flow | -$4,853 | -$6,330 | -$13,847 | -$8,458 |